Unity Biotechnology logo

Unity Biotechnology

A biotechnology company developing drugs and treatments to diminish negative health effects associated with aging.

3

Funding Rounds

$322.0m

Money raised

Overview

A biotechnology company developing drugs and treatments to diminish negative health effects associated with aging.

Funding series

Funding Series Analysis

The company Unity Biotechnology has raised a total of $116m in funding over 3 rounds.

Key Insights:

  • Unity Biotechnology Series B round, October 2016: $116m
  • Unity Biotechnology Inc funding round, March 2018: $55m
  • Unity Biotechnology funding round, August 2017: $151m
Unity Biotechnology logo
Unity Biotechnology Series B round, October 2016 $116m
Unity Biotechnology logo
Unity Biotechnology Inc funding round, March 2018 $55m
Unity Biotechnology logo
Unity Biotechnology funding round, August 2017 $151m

Industries

Unity Biotechnology is active in the following industries:
  • Medicine
  • Ageing
  • Engineering
  • Healthcare
  • Biotechnology
  • Biology
  • Biomedical engineering
  • Therapy
  • Technology
  • Drug development
  • Anti-Aging
  • Therapeutics
  • Drug discovery